Wetherby Asset Management Inc Sanofi Transaction History

Wetherby Asset Management Inc

$2.13 Billion
Q3 2024

A detailed history of Wetherby Asset Management Inc transactions in Sanofi stock. As of the latest transaction made, Wetherby Asset Management Inc holds 51,640 shares of SNY stock, worth $2.53 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

51,640

Previous 43,182 19.59%

Holding current value

$2.53 Million

Previous $2.1 Million 42.1%

% of portfolio

0.14%

Previous 0.1%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$48.54 - $58.53 $410,551 - $495,046	8,458 Added 19.59%	51,640 $2.98 Million
Q2 2024 Aug 14, 2024	BUY	$45.39 - $50.36 $240,430 - $266,756	5,297 Added 13.98%	43,182 $2.1 Million
Q1 2024 May 15, 2024	SELL	$45.75 - $52.48 $51,743 - $59,354	-1,131 Reduced 2.9%	37,885 $1.84 Million
Q4 2023 Feb 14, 2024	SELL	$43.13 - $54.79 $68,317 - $86,787	-1,584 Reduced 3.9%	39,016 $1.94 Million
Q3 2023 Nov 14, 2023	BUY	$50.95 - $55.2 $16,915 - $18,326	332 Added 0.82%	40,600 $2.18 Million
Q2 2023 Aug 14, 2023	BUY	$50.45 - $57.18 $84,100 - $95,319	1,667 Added 4.32%	40,268 $2.17 Million
Q1 2023 May 12, 2023	BUY	$45.86 - $54.45 $124,372 - $147,668	2,712 Added 7.56%	38,601 $2.1 Million
Q4 2022 Feb 14, 2023	BUY	$38.86 - $48.55 $260,167 - $325,042	6,695 Added 22.93%	35,889 $1.74 Million
Q3 2022 Nov 14, 2022	SELL	$37.22 - $100.5 $329,955 - $890,932	-8,865 Reduced 23.29%	29,194 $1.11 Million
Q2 2022 Aug 15, 2022	BUY	$48.99 - $57.46 $73,093 - $85,730	1,492 Added 4.08%	38,059 $1.9 Million
Q1 2022 May 16, 2022	BUY	$48.48 - $53.65 $28,118 - $31,117	580 Added 1.61%	36,567 $1.88 Million
Q4 2021 Feb 14, 2022	SELL	$47.07 - $52.35 $6,166 - $6,857	-131 Reduced 0.36%	35,987 $1.8 Million
Q3 2021 Nov 15, 2021	SELL	$47.89 - $53.12 $76,432 - $84,779	-1,596 Reduced 4.23%	36,118 $1.74 Million
Q2 2021 Aug 16, 2021	SELL	$49.36 - $54.25 $78,038 - $85,769	-1,581 Reduced 4.02%	37,714 $1.99 Million
Q1 2021 May 14, 2021	SELL	$45.46 - $50.51 $72,099 - $80,108	-1,586 Reduced 3.88%	39,295 $1.94 Million
Q4 2020 Feb 11, 2021	BUY	$45.3 - $51.62 $1.73 Million - $1.98 Million	38,270 Added 1465.72%	40,881 $1.99 Million
Q3 2020 Dec 16, 2020	SELL	$49.47 - $53.77 $1.85 Million - $2.01 Million	-37,386 Reduced 93.47%	2,611 $131,000
Q3 2020 Dec 16, 2020	SELL	$49.47 - $53.77 $166,862 - $181,366	-3,373 Reduced 7.78%	39,997 $2.01 Million
Q3 2020 Nov 13, 2020	BUY	$49.47 - $53.77 $23,943 - $26,024	484 Added 1.13%	43,370 $2.18 Million
Q2 2020 Aug 14, 2020	BUY	$42.91 - $52.5 $2,574 - $3,150	60 Added 0.14%	42,886 $2.19 Million
Q1 2020 May 06, 2020	BUY	$38.02 - $51.66 $186,906 - $253,960	4,916 Added 12.97%	42,826 $1.87 Million
Q4 2019 Jan 28, 2020	SELL	$44.25 - $50.86 $64,605 - $74,255	-1,460 Reduced 3.71%	37,910 $1.9 Million
Q3 2019 Oct 31, 2019	BUY	$40.34 - $46.64 $118,922 - $137,494	2,948 Added 8.09%	39,370 $1.82 Million
Q2 2019 Jul 25, 2019	BUY	$40.43 - $44.3 $35,335 - $38,718	874 Added 2.46%	36,422 $1.58 Million
Q1 2019 May 09, 2019	SELL	$40.83 - $45.43 $17,965 - $19,989	-440 Reduced 1.22%	35,548 $1.57 Million
Q4 2018 Jan 30, 2019	BUY	$41.48 - $45.59 $149,162 - $163,941	3,596 Added 11.1%	35,988 $1.56 Million
Q3 2018 Nov 07, 2018	BUY	$40.0 - $44.84 $120,720 - $135,327	3,018 Added 10.27%	32,392 $1.45 Million
Q2 2018 Jul 24, 2018	SELL	$37.63 - $41.22 $61,826 - $67,724	-1,643 Reduced 5.3%	29,374 $1.18 Million
Q1 2018 May 04, 2018	BUY	$38.98 - $45.76 $34,302 - $40,268	880 Added 2.92%	31,017 $1.24 Million
Q4 2017 Feb 09, 2018	SELL	$42.86 - $50.61 $65,575 - $77,433	-1,530 Reduced 4.83%	30,137 $1.3 Million
Q3 2017 Nov 13, 2017	BUY	$47.04 - $50.34 $1.49 Million - $1.59 Million	31,667	31,667 $1.58 Million

Others Institutions Holding SNY

# of Institutions

822

Shares Held

268M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $123B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.

Account

Wetherby Asset Management Inc Sanofi Transaction History